Could cinnamon become a natural treatment for metabolic syndrome?

By Lila Rouland | Published on December 5, 2025 | 3 min read


Metabolic syndrome (MetS) is an increasingly prevalent public health concern worldwide. It encompasses a cluster of conditions including hypertension, visceral obesity, hyperglycemia, dyslipidemia, and insulin resistance. These abnormalities—often linked to sedentary lifestyles and unbalanced diets—substantially increase the risk of cardiovascular disease and type 2 diabetes.

Given the limitations of pharmacological treatments, research is turning toward complementary approaches such as medicinal plants. Among them, cinnamon (Cinnamomum verum), rich in phenolic and volatile compounds, shows strong therapeutic potential thanks to its antidiabetic, anti-inflammatory, antioxidant, and hypolipidemic properties.  

What mechanisms explain cinnamon’s protective effects against metabolic syndrome?

Bioactive composition and physiological mechanisms

Cinnamon contains numerous active compounds, the most prominent being cinnamaldehyde, responsible for many of its pharmacological effects. This molecule enhances insulin sensitivity, lowers triglycerides, reduces visceral adiposity, and exerts thermogenic activity that promotes fat oxidation. Studies show that cinnamaldehyde inhibits the digestive enzymes α-amylase and α-glucosidase, thereby reducing intestinal glucose absorption and postprandial spikes. It also stimulates the glucose transporter GLUT4, increasing cellular glucose uptake.  


Effects on obesity and lipid disorders

Clinical trials in humans and animals have demonstrated cinnamon’s efficacy in reducing body fat mass, BMI, and waist circumference. When combined with physical activity, it significantly improves body composition. In rodent and zebrafish models, cinnamon decreases LDL cholesterol, triglycerides, and blood glucose while regulating lipid-related gene expression.

In trials involving postmenopausal women, daily doses of 2.4 mg for three months, combined with a hypocaloric diet, reduced body fat and modulated lipid metabolism. These findings are supported by hepatic lipase assays, glycemic markers, and liver enzyme measurements.  


Antidiabetic effects

Several clinical studies show that supplementing 3–6 g of cinnamon daily for 40 days significantly reduces fasting and postprandial blood glucose levels, as well as glycated hemoglobin (HbA1c). Cinnamon also increases serum insulin while improving pancreatic function.

Animal and human studies report that combining cinnamon with other extracts (fenugreek, onion, tea) enhances its hypoglycemic effect—sometimes outperforming metformin in certain postprandial measures.  


Effects on dyslipidemia and hypertension

Cinnamaldehyde significantly reduces LDL, triglycerides, and total cholesterol while increasing HDL levels. In ovariectomized rats, it inhibits aortic lipid accumulation and oxidative stress. In humans, adding cinnamon (1–1.5 g/day) improves lipid responses to aerobic exercise and significantly lowers cardiovascular risk markers.

Regarding blood pressure, a study of 200 hypertensive patients found that daily consumption of 2 g of cinnamon combined with a balanced diet led to significant reductions in systolic and diastolic blood pressure, as well as waist-to-hip ratio.  

Does cinnamon have a role in the clinical management of metabolic syndrome?

Thanks to its rich profile of bioactive compounds, cinnamon stands out as a promising natural therapeutic option for metabolic syndrome. Its beneficial effects on glycemic control, lipid profile, adiposity, and blood pressure are well established, with good tolerability at moderate doses (up to 6 g/day).

However, despite these encouraging results, the absence of standardized dosing and interindividual variability highlight the need for further research, particularly large-scale clinical trials. It remains essential to evaluate long-term safety, especially when used at high or prolonged doses.

Integrating cinnamon into prevention and management strategies for chronic diseases represents a promising avenue for phytopharmacology.         

Read next: Fibers & Diabetes: is everything equal?